Connor Clark & Lunn Investment Management Ltd. bought a new position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 21,586 shares of the medical device company's stock, valued at approximately $1,984,000.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. State Street Corp lifted its stake in shares of Cooper Companies by 1.2% in the third quarter. State Street Corp now owns 8,590,689 shares of the medical device company's stock worth $947,897,000 after buying an additional 104,521 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock worth $543,979,000 after buying an additional 573,908 shares in the last quarter. Geode Capital Management LLC lifted its position in Cooper Companies by 1.0% during the third quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company's stock valued at $527,476,000 after purchasing an additional 48,559 shares during the period. Victory Capital Management Inc. lifted its position in Cooper Companies by 14.6% during the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after purchasing an additional 574,899 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Cooper Companies by 11.9% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company's stock valued at $200,665,000 after purchasing an additional 194,118 shares during the period. Institutional investors own 24.39% of the company's stock.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on COO shares. StockNews.com downgraded shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Wednesday, December 11th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Citigroup lowered their price objective on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Piper Sandler restated an "overweight" rating and set a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Finally, Robert W. Baird lowered their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $110.25.
Read Our Latest Research Report on COO
Cooper Companies Price Performance
Shares of NASDAQ COO traded up $1.32 during midday trading on Friday, reaching $81.71. The stock had a trading volume of 3,706,219 shares, compared to its average volume of 1,282,694. The stock has a 50-day moving average of $90.05 and a 200-day moving average of $98.14. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The company has a market capitalization of $16.34 billion, a price-to-earnings ratio of 41.90, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 12-month low of $77.05 and a 12-month high of $112.38.
Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.92. The firm had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.
Cooper Companies Company Profile
(
Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Featured Articles
Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
